Upashita IV injection for dialysis 150μg syringe, manufactured by Sanwa Chemical Research Institute, contains Upacicalcet sodium hydrate. This calcimimetic agent is used to enhance the sensitivity of calcium-sensing receptors on parathyroid glands, which helps reduce parathyroid hormone secretion in patients on hemodialysis. It is supplied as a 150μg/1mL/1 tube injectable drug (YJ code: 3999460G4020).
Upashita IV injection for dialysis 150μg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →